Connect with us
[the_ad id="89560"]

COVID-19

Excess Deaths in Canada and around the world remain astoundingly high in 2023

Published

3 minute read

From the YouTube channel of British health researcher Dr. John Campbell

During World War II in the UK, Germany repeatedly bombed English cities night after night for months on end.  Thousands were killed.  In total, though World War II, about 70,000 English civilians were killed.

In the last two years, the UK has suffered over 101,000 “excess deaths”. These are deaths that data tells us should not be expected to happen at this time.  In other words, people are dying earlier than should be expected.

This isn’t only happening in the UK.  The numbers are astoundingly high in Canada, Australia, the US and in most western countries with modern medical systems.

In this short video presentation Dr. John Campbells shows the numbers and asks a critical question.

Excess deaths by week, 2023 https://data-explorer.oecd.org https://stats.oecd.org/index.aspx?que…

Australia, weeks 1 – 34, 2023 14,710 (16.8%) Covid deaths, 4,977

Australia, 2022, weeks 1 – 52 29,738 (18.7%) Australia, excess deaths 2022 + 2023 = 44,448

Austria, week 1 – 44, 2023 4,444 (6.5%)

Canada, weeks 1 – 33, 2023 28,400 (16.7%) Covid deaths, 4,613

Canada, 2022 61,468 (22.3%) Canada, excess deaths 2022 + 2023 = 89,868

Denmark, weeks 1 – 44, 2023 3,052 (6.9%) Covid deaths, 347

Denmark, 2022 5,871 (11%) Denmark, excess deaths 2022 + 2023 = 8,923

Finland, weeks 1 – 44, 2023 4,627 (10.5%)

France, weeks 1 – 44, 2023 22,268 (4.9%) Covid deaths, 5,565

France, 2022 71,751 (11.9%)

Germany, weeks 1 – 44, 2023 59,039 (7.7%)

Germany, 2022 134, 578 (14.9%)

Greece, weeks 1 – 44, 2023 5,132 (5.2%)

Iceland, weeks 1 – 44, 2023 209 (11.5%) Covid deaths, 0

Iceland, 2022 446 (20.2%)

Israel, weeks 1 – 44, 2023 4,303 (11.8%) Covid deaths, 640

Israel, 2022 7,050 (15.4%)

Italy, weeks 1 – 44, 2023 938 (0.28%)

Netherlands, weeks 1 – 44, 2023 14,209 (11.3%)

Netherlands, 2022 19,326 (13.2%)

New Zealand, weeks, 1 – 44, 2023 3,960 (14.5%)

New Zealand, 2022 5,787 (17.6%)

Norway, weeks 1 – 44, 2023 1,885 (5.7%)

Norway, 2022 4,980 (12.5%)

Portugal, weeks 1 – 44, 2023 5,184 (6.3%)

Spain, weeks 1 – 44, 2023 11,948 (3.7%)

Switzerland, 1 – 44, 2023 2,063 (3.9%)

UK, weeks 1 – 44, 2023 49,389 (9.44%) Covid deaths, 18,591

UK, 2022 52,514 (9.26%) UK excess deaths 2022 + 2023 = 101,903

Height of the Blitz, September 1940 to May 1941 UK civilian deaths, 40,000

Total civilian deaths for WW2, 70,000

US, weeks 1 – 37, 2023 155,763 (7.8%) Covid deaths, 76,187

US, 2022 495,749 (17.53) US excess deaths 2022 + 2023 = 651,512

Total US deaths in Vietnam war The U.S. National Archives shows that 58,220 U.S. soldiers perished. https://www.worldatlas.com/articles/h…

Hungary, weeks 1 – 44, 2023 -3,785 (-3.2%)

Poland, weeks 1 – 43, 2023 104 (0.13%)

Slovak republic, weeks 1 – 43, 2023 -774 (-1.54%)

Sweden, weeks 1 – 44, 2023 -529 (0.6%)

COVID, the untold story. So much more makes sense after this book and my first illuminating discussion with Dr. Craig. Get your copy in the UK here: https://www.amazon.co.uk/Expired-unto…

For friends in the US get your copy here, https://www.amazon.com/Expired-untold…

This dataset presents the latest data on All-cause death statistics Excess mortality and COVID-19 deaths, by week, for all OECD countries for which data are available. The expected number of deaths is based on the average number of deaths for the same week, (2015-19) This baseline could be considered a lower estimate of the expected number of deaths since both population growth and an ageing population would be expected to push up the number of deaths observed each year. For example, New Zealand saw its population grow by around 9% since 2015, with the number of people aged 65 and over increasing by 18%.

COVID-19

The New York Times Admits Injuries from COVID-19 Shots

Published on

From Heartland Daily News

By AnneMarie Schieber

“This is a promising start, but what about the dead?”

The COVID-19 shots have caused multiple, serious injuries, an article in The New York Times acknowledged on May 4.

It is the first time the self-described newspaper of record has reported on the severe side effects from the vaccines, since the massive inoculation campaign that went into full swing starting in January 2021. The article profiled several health professionals with advanced degrees who suffered debilitating injuries ranging from neurological disorders, shingles, hearing loss, tinnitus, Guillain-Barre Syndrome, and racing hearts, weeks and months after their COVID-19 shots.

‘I’m Told I’m Not Real’

The patients, all familiar with the internal workings of the health care system, described their utter frustration with their complaints not being taken seriously.

“I can’t get the government to help me,” Shaun Barcavage, a 54-year-old nurse practitioner from New York City told the Times. Barcavage now suffers from tinnitus after suffering from stinging in his eyes, mouth, and genitals upon getting his first COVID shot. “I’m told I’m not real. I’m told I’m coincidence.”

Similarly, Gregory Poland, editor-in-chief of the journal Vaccine, found little interest in his condition, according to the Times. Poland has urged his contacts at the Centers for Disease Control to examine the connection between the shots and tinnitus, which has afflicted him.

“I just don’t get any sense of movement,” Poland told the Times. “If they have done studies, those studies should be published.”

Changing Times?

The 3,244-word article—which the Times says was the result of months of investigation—highlights reports of COVID shot injuries reported by patients, conservative media outlets, and courageous doctors almost immediately after the vaccine campaign got underway, but were dismissed by the Times and other mainstream media outlets.

“That it took The New York Times more than three years to report on COVID side effects is just the latest indictment against our corrupt corporate legacy media,” said Jim Lakely, vice president and communications director at The Heartland Institute, which publishes Health Care News. “Back when such reporting would have been just as true, and actually mattered, the likes of The New York Times characterized all talk of negative side effects of a rushed COVID treatment as ‘disinformation’ and unproven ‘conspiracy theories.’”

Traditionally, journalism’s role was to remain neutral and to be skeptical of power, but the pandemic proved that corporate media outlets can no longer be trusted to report the news, and the article is the Times’ attempt to rehabilitate its image, says Lakely.

“The same legacy media that led the charge to de-platform and shame any free-thinking American who dared to question government narratives and mandates during the pandemic does not get points, for now, starting to gently report what has been true since the spring of 2020,” Lakely said.

Never Mind Deaths

“This is a promising start, but what about the dead?” wrote Jeff Childers on May 4 in his Coffee and COVID Substack. Childers has meticulously documented the “sudden deaths” of young, healthy people who received the COVID shots.

“Never mind!” wrote Childers. “Here we find the first serious gap in the article’s coverage. The Times avoided this difficult issue, only briefly referring to possible deaths. But maybe it was too much to expect in this cautious, tentative first step toward officially acknowledging that ‘Houston, we may have a problem.’”

Sudden deaths began getting serious attention late in 2022 after insurance executives started noticing a rise in death claims of young, working-age people.  Pilots, whose health is closely monitored, oddly began dying mid-flight.

     Also missing from the article is any mention of Peter McCullough, M.D., who has become one of the most recognizable names around the globe warning people about the mRNA shots. “No, I was not contacted,” McCullough told Health Care News.

‘Politics At Play’

Childers says the timing of the Times article is suspicious, noting that former CNN anchor Chris Cuomo, who championed pandemic mitigation measures, went on national television recently to discuss his COVID shot injuries.

“I’m speculating, a lot, but cynically I sense politics at play,” wrote Childers. “We’re six months out from the election. Who does admitting even partial failure of the vaccine program help, politically, and who does it hurt? The acknowledgment of the reality of widespread, unaddressed vaccine injuries would seem to hurt President Trump the most.”

AnneMarie Schieber ([email protected]is the managing editor of Health Care News.

Continue Reading

Brownstone Institute

Medical Elites’ Disgrace Over Ivermectin

Published on

From the Brownstone Institute

BY David GortlerDAVID GORTLER 

In the wake of the FDA settling a lawsuit brought against it for wantonly and aggressively smearing ivermectin, the agency has deleted its postings. That’s good, but we shouldn’t forget how egregiously it mischaracterized the drug, ignored copious evidence in its favor, and portrayed its proponents as dangerous crackpots.

About 30 months ago, America’s FDA was publishing articles with headlines like this: “Should I take ivermectin to treat COVID?” Answer: No. The agency also told Americans not to use ivermectin to prevent Covid. Then, in what became known as its infamous “horse tweet,” the FDA even patronizingly told Americans: “Seriously, y’all. stop it.

Prescribers who advocated for alternate treatments like ivermectin or hydroxychloroquine were mocked online by America’s “trusted journalists” as being part of a “right-wing conspiracy” and labeled “hucksters.” Those who didn’t demure to the Covid mRNA or other Big Pharma treatment narratives were banned, fired, and spoken harshly about around the world and into the reaches of the stratosphere in what seemed like coordinated messaging.

Many clinicians lost their jobs – at best. At worst, their reputations, practices, finances, and careers were shattered. If that was not bad enough, after losing their jobs, state medical and pharmacy boards initiated legal proceedings against their licensure, singling out their “off-label” Covid treatments, despite other off-label treatments being a near-ubiquitous component of pharmacy and medical practice.

A screenshot of a social media post Description automatically generated

Within days of FDA’s initial postings above, the American Pharmacist’s Association (APhA) the American Society of Health System Pharmacists (ASHP), and the American Medical Association (AMA) all collaborated to release a joint press release condemning doctors who prescribed ivermectin to treat Covid, but it appears that these organizations, instead of actually performing independent analysis of primary literature data, blindly regurgitated FDA, CDC, and NIH plus other government and Big Pharma talking points “strongly opposing” ivermectin use.

For generations and especially during the Covid pandemic, professionals depended on these “elite” medical groups. Some of them have existed for around 170 years and have around $150 million to $1.2 billion in assets, so they clearly had the history, personnel, and wherewithal to objectively examine published data. Even beyond that, the AMA has several floors in a skyscraper in Chicago and the APhA’s Constitution Avenue’s “landmark headquarters” is so luxuriant that it is advertised and utilized as a wedding venue.

Of course, that extravagance was paid for by millions of pharmacists, physicians, and benefactors who expected these organizations to act as a checksum and ensure excellent clinical practice standards. These medical organizations have a duty to honor their histories, responsibilities, and ethical duties to better the human condition through verified scientific evidence. Instead, they appeared to outrageously abandon their obligations from their lofty positions of respect, comfort, money, and power.

APhA, ASHP, and AMA Clinical Declarations Now Indefensible:

On March 22, the FDA rightly acquiesced and agreed to remove their anti-ivermectin postings due to 1) a lawsuit filed against them and 2) the impossible task of having to defend themselves with an overwhelming amount of data disagreeing with not only dispensing medical recommendations, but the published data backing their Covid-19 use (e.g., see below).

With that gone, the APhA, ASHP, and AMA assertions suddenly have no leg upon which to stand.

Several non-FDA links within their press releases have (unsurprisingly) also quietly vanished with no explanation. NIH references are slated to be shut down, on top of multiple FDA and CDC links already no longer working.

Ivermectin Mechanism of Action, History and Evidence:

The broad antiviral mechanism of action of ivermectin is complicated and may partially involve blocking the uptake of viral proteins, but the bottom line is that it has been shown to yield positive results in a variety of published results for Covid-19. Had APhA, ASHP, and AMA pharmacists and physicians independently examined the data, (as I, just one drug-safety analyst without fancy headquarters, have done) rather than simply parroting now-deleted narratives of others, they would have learned that ivermectin works as an antiviral.

It has an extensively proven track record of being not just safe – but astonishingly safe for a variety of viral diseases. This is not breaking or fringe science; it has been known for years. Ivermectin is such a safe and effective drug that back in 2015 it was the first drug for infectious disease associated with a Nobel Prize in 60 years.

While I have stacks of electronic files and printed materials, dog-eared and food/drink-stained, there is a most elegantly presented meta-analysis website designed by some brainy and web-savvy scientists detailing over 100 studies from over 1,000 different scientists, involving over 140,000 patients in 29 countries describing the benefit and safety of ivermectin for Covid-19 treatment. It actually appears to be more extensive than Cochrane’s outdated review of ivermectin which only examined 14 trials – and excluded seven of them from consideration.

A close-up of a blue sign Description automatically generated

According to these data, consisting of smaller international publications that include real-world findings and small observational studies, ivermectin shows a statistically significant lower Covid-19 risk as detailed in the image above.

The less-positive findings associated with late treatment/viral clearance/hospitalization data cohort were associated with delayed administration. That is because any late-state use of antiviral pharmacology tends to be ineffective after hundreds of millions of viral replications have taken place – whether it’s cold sores, influenza, AIDS, or Covid-19.

ASHP, APhA, and AMA Press Releases Contradict Available Data and Clinical Practice Standards:

When the FDA scolded Americans not to use ivermectin for Covid-19, on April 25, 2021, there were 43 different published manuscripts showing its potential benefit. Around three months later, on August 21, the FDA released its infamous horse/cow tweet which implied that ivermectin was only for animals, not humans. This “doubling down” occurred as an additional 20 studies had subsequently been written detailing additional benefits for Covid-19. See the timeline below:

In the picture shown above, the BLUE circles shown are studies which detail positive ivermectin study findings and the RED circles are negative. Negative data exists, but the positive ivermectin findings outnumber them both in study quantity and study size (illustrated by the circle sizes), according to meta analysis data published at: c19ivm.org

Multiple APhA/ASHP/AMA statements ignored published scientific and clinical evidence. Specifically, statements declaring the: “Use of ivermectin for the prevention and treatment of COVID-19 has been demonstrated to be harmful to patients” (bold emphasis theirs) are objectively inaccurate. I do not know on what basis those statements were made. The recommendation to healthcare professionals to …counsel patients against use of ivermectin as a treatment for COVID-19, including emphasizing the potentially toxic effects of this drug” represents a departure from pharmacist and physician practice standards.

The absurdity of the latter statement is quite outrageous. Pharmacists and physicians know that all drugs have “…potentially toxic effects” so if they applied the standard of “emphasizing potentially toxic effects” while discussing every prescribed medication, few if any patients would ever take any of their medications. The APhA/ASHP/AMA discriminatory hostility towards ivermectin was not only clinically unjustified and irresponsible; it was – as far as I know – without precedent.

These anti-ivermectin talking points also benefited new Big Pharma product advancement including the rebounding, overpriced taxpayer-funded boondoggle of Paxlovid and Remdesivir, such a “safe and effective” drug that hospitals had to be heavily incentivized (i.e., bribed) to entice nurses, physicians, and hospital administrators to promote its use with a staggering 20% “bonus” on the entire hospital bill paid by our federal government. Remdesivir quickly earned the sardonic nickname of “run-death-is-near” by American Frontline Nurses and others, due to serious questions about its clinical benefit.

Why were federal agencies’ and professional organizations’ talking points against ivermectin not backed by independent, original APhA/ASHP/AMA data examinations? That question needs to be thoroughly probed with regard to potential regulatory capture within these groups.

Both then and now, those FDA webpages, postings, and tweets were not just biased. They were irresponsible in their denigrating ivermectin as an off-label treatment, which is why they are now gone.

The question is, who was worse? The FDA for overstepping its congressional authority in not just making medical recommendations, but making recommendations ignoring data, or the servile “independent” elite professional organizations exuberantly echoing a narrative?

Prescient or not, here is an excerpt of the expert panel congressional testimony to the Covid Select House Oversight Committee, explaining the FDA’s disparaging ivermectin versus promoting mRNA injections using an automobile analogy, delivered just one day prior to the FDA’s yielding to physicians’ lawsuit to remove its postings denigrating ivermectin:

Heritage Foundation on X: ““To the countries, physicians, & pharmacists who prescribed ivermectin or hydroxychloroquine, I would like to tell you right now, you were right.” Dr. Gortler obliterated the “science” Americans were expected to believe about COVID treatments and the COVID vaccine in Congress… https://t.co/UJInVqdSdb” / X (twitter.com)

Despite FDA Settlement and Data Abundance, the Press is Still Anti-Ivermectin

Even after the FDA’s about-face, on March 26, 2024, a Los Angeles Times journalist published a column calling the removal of FDA tweets “groundless” unilaterally declaring ivermectin is still “conclusively shown to be useless against COVID-19,” comparing ivermectin to “snake oil,” and describing those who advocate for it as “purveyors of useless but lucrative nostrums” …whatever that means. (Regarding the ‘lucrative’ claim, it is worth noting that since ivermectin is generic and inexpensively available, it is not ‘lucrative’ to anyone.) It also referenced ivermectin lacking “scientific validation,” even though the above-cited data abundantly indicates otherwise.

Regarding the FDA’s choice to settle its lawsuit disparaging ivermectin, the FDA’s Center for Drug Evaluation and Research leadership isn’t “shooting itself in the foot” as the Times says. It seems that the FDA is indirectly attempting to prevent further embarrassment likely because it now realizes that its ivermectin assertions were wrong and outdated with every passing day. But where does that leave the APhA, ASHP, or AMA who heavily relied on these now deleted FDA links in their press releases?

The APhA, ASHP, AMA Response to the FDA’s Removal of Postings Used in Press Releases? An Embarrassing Silence:

Over a month later, and as of this publication date, none of these organizations have a single thing to say about their previous press releases quoting the now-removed FDA articles and tweets. In fact, here is an indication of their concerns: one week after the FDA acquiesced to remove its postings in ivermectin, APhA’s newly elected speaker chair and pharmacist Mary Klein is “happy danc[ing]” and giving her official acceptance speech wearing Mickey Mouse ears. ASHP’s (A/K/A “#MedicationExperts”) still shows its official page with clinicians wearing ineffective, unnecessary surgical masks despite the pandemic having ended well over a year ago and Cochrane reviews indicating that this sort of masking is almost certainly ineffective. AMA officials are making multiple posts on transgender issues and declaring climate change a public health crisis, – all while fully ignoring its impactful, incorrect, inappropriate statements on ivermectin.

Take a look:

The APhA, ASHP, and AMA have remained conspicuously silent on this topic while focusing their newsfeeds on everything but. To this day, their press releases remain online, with multiple dead links to government agencies. In blindly backing incorrect narratives pointing to removed web pages, they are now all alone in their ivermectin declarations.

Bottom line: ivermectin was and is safe, and more than likely effective for Covid when timed and dosed correctly, and under medical supervision, despite what was declared by organizations and federal officials. In fact, ivermectin’s general antiviral activity might even be helpful for bird flu (avian influenza) in animals and humans, in lieu of another novel adverse-event-ridden “warp speed” mRNA “vaccine” with an endless boondoggle of boosters.

The past and current record on ivermectin needs to be set straight. We know there is an important (but untransparent) list of who is responsible for misrepresenting published data, but will anyone be held accountable?

DISCLAIMER:  Do NOT discontinue or initiate taking ANY drug without first discussing it with a pharmacist or physician you know and trust. 

Author

  • David Gortler

    Dr. David Gortler, a 2023 Brownstone Fellow, is a pharmacologist, pharmacist, research scientist and a former member of the FDA Senior Executive Leadership Team who served as senior advisor to the FDA Commissioner on matters of: FDA regulatory affairs, drug safety and FDA science policy. He is a former Yale University and Georgetown University didactic professor of pharmacology and biotechnology, with over a decade of academic pedagogy and bench research, as part of his nearly two decades of experience in drug development. He also serves as a scholar at the Ethics and Public Policy Center

Continue Reading

Trending

X